Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement

Common Size IS
Op Efficiency
Credit Analysis

Intellia Therapeutics, Inc. (NTLA)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-05-22Dec-31-21Dec-05-21Dec-31-20Dec-05-20Dec-31-19Dec-31-18
   10-K8-K10-K8-K10-K8-K10-K10-K
Revenues   [+]52.1420.033.1229.858.0150.443.130.4
            Revenue growth  57.7%82.8%-43.0%52.8%34.5% 41.6%16.5%
Cost of goods sold  454.3510.3300.9300.9194.6242.8149.50.0
Gross profit  -402.2-90.3-267.9-71.1-136.6-92.4-106.430.4
            Gross margin  -771.6%-21.5%-810.4%-30.9%-235.5%-61.4%-246.8%100.0%
Selling, general and administrative   [+]56.090.3 71.1 44.2 32.2
Research and development         89.1
Equity in earnings   -11.1 -1.3    
Other operating expenses  -56.0291.0 125.7    
EBITDA   [+]-394.6 -261.0 -130.3 -100.8-86.4
            EBITDA margin  -757.1%-114.9%-789.5%-117.1%-224.6%-90.8%-233.8%-283.9%
Depreciation and amortization  7.6 6.9 6.3 5.64.5
EBIT   [+]-402.2-482.7-267.9-269.2-136.6-136.6-106.4-90.9
            EBIT margin  -771.6%-114.9%-810.4%-117.1%-235.5%-90.8%-246.8%-298.6%
Non-recurring items   [+]56.0-13.5      
Interest income  8.58.51.31.32.4 6.85.5
Other income (expense), net  -24.6-13.5-1.3  2.4  
Pre-tax income  -474.2-474.2-267.9-267.9-134.2-134.2-99.5-85.3
Income taxes  0.00.00.00.00.00.00.00.0
            Tax rate  0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Net income  -474.2-474.2-267.9-267.9-134.2-134.2-99.5-85.3
            Net margin  -909.8%-112.9%-810.5%-116.6%-231.5%-89.2%-230.9%-280.4%
   
Basic EPS   [+]($6.16)($6.16)($3.78)($3.78)($2.40)($2.40)($2.11)($1.98)
Diluted EPS   [+]($6.16)($6.16)($3.78)($3.78)($2.40)($2.40)($2.11)($1.98)
   
Shares outstanding (basic)   [+]77.077.070.970.956.056.047.243.1
Shares outstanding (diluted)   [+]77.077.070.970.956.056.047.243.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy